(Q43992057)

English

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women (English)

1 reference

Europe PubMed Central

28 November 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

cardiovascular disease in women

0 references

Dimitri P Mikhailidis

6

object named as

Dimitri P Mikhailidis

1 reference

Europe PubMed Central

28 November 2017

author name string

Gordana M Prelevic

1

1 reference

Europe PubMed Central

28 November 2017

Pandina Kwong

2

1 reference

Europe PubMed Central

28 November 2017

Dominic J Byrne

3

1 reference

Europe PubMed Central

28 November 2017

I Anita Jagroop

4

1 reference

Europe PubMed Central

28 November 2017

Jean Ginsburg

5

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

28 November 2017

Fertility and Sterility

1 reference

Europe PubMed Central

28 November 2017

77

1 reference

Europe PubMed Central

28 November 2017

945-951

1 reference

Europe PubMed Central

28 November 2017

5

1 reference

Europe PubMed Central

28 November 2017

Cardiovascular health and disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipo

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Effects of tibolone on lipoprotein(a) and HDL subfractions.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Lipoprotein(a) immunoassays: comparison of a semi-quantitative latex method and two monoclonal enzyme immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

The renaissance of C reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Hormone replacement therapy and increased plasma concentration of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Hormone replacement therapy and glucose tolerance in EPIC-Norfolk: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903078-9

7 January 2021

Identifiers

10.1016/S0015-0282(02)03078-9

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43992057&oldid=2105387163"